Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.

Megluxin 100 ml

Nr.
801314
Brand:
Hipra
Batch:
08S4-1
Expiry date:
02-Sep-2022

Flunixin meglumine, injectable solution

More info

Hipra - Megluxin 100ml (50mg)

Flunixin (meglumine) is a NSAID with an analgesic and antipyretic activity. It acts by blocking the biosynthesis of prostaglandins upon inhibition of cyclo-oxigenase.
The aromatic rings of flunixin initially undergo hydroxylation followed by conjugation. The conjugate can then suffer an alkaline hydroxylation in the horses which increases the quantity of the free active ingredient. The mean half-life of the elimination of 1.1mg/kg b.w. of the product is 1.5 hours. Elimination principally occurs by the urinary route. 

Indications:
Horses: Inflammations and Colics
- To treat inflammation and pain associated with muscular-skeletal alterations
- To treat visceral pain associated with colics
- To prevent endotoxic shock from acute gastrointestinal diseases.  

Swine: MMA Syndrome.
- help in the treatment of the mastitis-metritis-agalactica syndrome in sows. 

Cattle: Inflammations and Respiratory infections. 
- to treat chronic inflammation associated with respiratory tract infections. 

More Information
Nr.801314
Registration numberCascade
BrandHipra
Chilled itemNo
Active IngredientFlunixin
Target speciesCattle, Horse, Swine
Legal status of supplyPOM
Route of administrationInjectable
Batch08S4-1
Expiry dateSep 2, 2022
Units per outer box12
Ingredients Flunixin Meglumine
© 2021 Grovet B.V. All rights reserved.